Iron supplementation moderates but does not cure the Belgrade anemia

Michael Garrick, Donna Scott, Susannah Walpole, Eric Finkelstein, Joy Whitbred, Sandeep Chopra, Lalitha Trivikram, David Mayes, Daphne Rhodes, Kimberly Cabbagestalk, Rahmi Oklu, Adnan Sadiq, Brett Mascia, James Hoke, Laura Garrick

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Belgrade rats inherit microcytic, hypochromic anemia as an autosomal recessive trait (gene symbol b). Erythrocytes and tissue are iron deficient in the face of elevated TIBC (total iron binding capacity) and percent iron saturation; iron injections increased the number of erythrocytes but their appearance remained abnormal. We have investigated iron supplements to improve husbandry of b/b rats and to learn more about the underlying defect and its tissue distribution. Weekly IM (intramuscular) injections of iron-dextran (Imferon at 30 mg kg-1) improved the anemia but did not alter the red cell morphology. Certain diets also improved the health of b/b rats when compared to standard rat chows by the criteria of weight, survival to adulthood, hematology and reproduction. The critical nutritional factor turned out to be iron bioavailability, with ferrous iron added to the diet improving the health of Belgrade rats without affecting the underlying erythroid defect. Tissue iron measurements after dietary or parenteral supplementation confirmed the iron deficient status of untreated b/b rats and established that dietary ferrous iron partially relieved this deficiency, with injections leading to greater amounts of tissue iron, Serum iron and TIBC were also found to be elevated in untreated b/b rats, with dietary supplementation decreasing but not eliminating the elevation in TIBC. These studies indicate that iron supplements can improve the health of b/b rats without altering the underlying defect and also suggest that the mutation could alter iron uptake in the GI (gastrointestinal) tract.

Original languageEnglish (US)
Pages (from-to)65-76
Number of pages12
JournalBioMetals
Volume10
Issue number2
StatePublished - May 17 1997
Externally publishedYes

Fingerprint

anemia
Anemia
Iron
iron
Rats
rats
binding capacity
Tissue
Health
Nutrition
Defects
Iron-Dextran Complex
Dietary Iron
Diet
Recessive Genes
injection
Injections
Erythrocyte Count
Intramuscular Injections
Dextran

Keywords

  • Belgrade rat
  • Dietary iron
  • Ferrous
  • Parenteral iron
  • Serum iron

ASJC Scopus subject areas

  • Biomaterials
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Metals and Alloys

Cite this

Garrick, M., Scott, D., Walpole, S., Finkelstein, E., Whitbred, J., Chopra, S., ... Garrick, L. (1997). Iron supplementation moderates but does not cure the Belgrade anemia. BioMetals, 10(2), 65-76.

Iron supplementation moderates but does not cure the Belgrade anemia. / Garrick, Michael; Scott, Donna; Walpole, Susannah; Finkelstein, Eric; Whitbred, Joy; Chopra, Sandeep; Trivikram, Lalitha; Mayes, David; Rhodes, Daphne; Cabbagestalk, Kimberly; Oklu, Rahmi; Sadiq, Adnan; Mascia, Brett; Hoke, James; Garrick, Laura.

In: BioMetals, Vol. 10, No. 2, 17.05.1997, p. 65-76.

Research output: Contribution to journalArticle

Garrick, M, Scott, D, Walpole, S, Finkelstein, E, Whitbred, J, Chopra, S, Trivikram, L, Mayes, D, Rhodes, D, Cabbagestalk, K, Oklu, R, Sadiq, A, Mascia, B, Hoke, J & Garrick, L 1997, 'Iron supplementation moderates but does not cure the Belgrade anemia', BioMetals, vol. 10, no. 2, pp. 65-76.
Garrick M, Scott D, Walpole S, Finkelstein E, Whitbred J, Chopra S et al. Iron supplementation moderates but does not cure the Belgrade anemia. BioMetals. 1997 May 17;10(2):65-76.
Garrick, Michael ; Scott, Donna ; Walpole, Susannah ; Finkelstein, Eric ; Whitbred, Joy ; Chopra, Sandeep ; Trivikram, Lalitha ; Mayes, David ; Rhodes, Daphne ; Cabbagestalk, Kimberly ; Oklu, Rahmi ; Sadiq, Adnan ; Mascia, Brett ; Hoke, James ; Garrick, Laura. / Iron supplementation moderates but does not cure the Belgrade anemia. In: BioMetals. 1997 ; Vol. 10, No. 2. pp. 65-76.
@article{1f4f47d66f6549068c26e14b8870b987,
title = "Iron supplementation moderates but does not cure the Belgrade anemia",
abstract = "Belgrade rats inherit microcytic, hypochromic anemia as an autosomal recessive trait (gene symbol b). Erythrocytes and tissue are iron deficient in the face of elevated TIBC (total iron binding capacity) and percent iron saturation; iron injections increased the number of erythrocytes but their appearance remained abnormal. We have investigated iron supplements to improve husbandry of b/b rats and to learn more about the underlying defect and its tissue distribution. Weekly IM (intramuscular) injections of iron-dextran (Imferon at 30 mg kg-1) improved the anemia but did not alter the red cell morphology. Certain diets also improved the health of b/b rats when compared to standard rat chows by the criteria of weight, survival to adulthood, hematology and reproduction. The critical nutritional factor turned out to be iron bioavailability, with ferrous iron added to the diet improving the health of Belgrade rats without affecting the underlying erythroid defect. Tissue iron measurements after dietary or parenteral supplementation confirmed the iron deficient status of untreated b/b rats and established that dietary ferrous iron partially relieved this deficiency, with injections leading to greater amounts of tissue iron, Serum iron and TIBC were also found to be elevated in untreated b/b rats, with dietary supplementation decreasing but not eliminating the elevation in TIBC. These studies indicate that iron supplements can improve the health of b/b rats without altering the underlying defect and also suggest that the mutation could alter iron uptake in the GI (gastrointestinal) tract.",
keywords = "Belgrade rat, Dietary iron, Ferrous, Parenteral iron, Serum iron",
author = "Michael Garrick and Donna Scott and Susannah Walpole and Eric Finkelstein and Joy Whitbred and Sandeep Chopra and Lalitha Trivikram and David Mayes and Daphne Rhodes and Kimberly Cabbagestalk and Rahmi Oklu and Adnan Sadiq and Brett Mascia and James Hoke and Laura Garrick",
year = "1997",
month = "5",
day = "17",
language = "English (US)",
volume = "10",
pages = "65--76",
journal = "BioMetals",
issn = "0966-0844",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Iron supplementation moderates but does not cure the Belgrade anemia

AU - Garrick, Michael

AU - Scott, Donna

AU - Walpole, Susannah

AU - Finkelstein, Eric

AU - Whitbred, Joy

AU - Chopra, Sandeep

AU - Trivikram, Lalitha

AU - Mayes, David

AU - Rhodes, Daphne

AU - Cabbagestalk, Kimberly

AU - Oklu, Rahmi

AU - Sadiq, Adnan

AU - Mascia, Brett

AU - Hoke, James

AU - Garrick, Laura

PY - 1997/5/17

Y1 - 1997/5/17

N2 - Belgrade rats inherit microcytic, hypochromic anemia as an autosomal recessive trait (gene symbol b). Erythrocytes and tissue are iron deficient in the face of elevated TIBC (total iron binding capacity) and percent iron saturation; iron injections increased the number of erythrocytes but their appearance remained abnormal. We have investigated iron supplements to improve husbandry of b/b rats and to learn more about the underlying defect and its tissue distribution. Weekly IM (intramuscular) injections of iron-dextran (Imferon at 30 mg kg-1) improved the anemia but did not alter the red cell morphology. Certain diets also improved the health of b/b rats when compared to standard rat chows by the criteria of weight, survival to adulthood, hematology and reproduction. The critical nutritional factor turned out to be iron bioavailability, with ferrous iron added to the diet improving the health of Belgrade rats without affecting the underlying erythroid defect. Tissue iron measurements after dietary or parenteral supplementation confirmed the iron deficient status of untreated b/b rats and established that dietary ferrous iron partially relieved this deficiency, with injections leading to greater amounts of tissue iron, Serum iron and TIBC were also found to be elevated in untreated b/b rats, with dietary supplementation decreasing but not eliminating the elevation in TIBC. These studies indicate that iron supplements can improve the health of b/b rats without altering the underlying defect and also suggest that the mutation could alter iron uptake in the GI (gastrointestinal) tract.

AB - Belgrade rats inherit microcytic, hypochromic anemia as an autosomal recessive trait (gene symbol b). Erythrocytes and tissue are iron deficient in the face of elevated TIBC (total iron binding capacity) and percent iron saturation; iron injections increased the number of erythrocytes but their appearance remained abnormal. We have investigated iron supplements to improve husbandry of b/b rats and to learn more about the underlying defect and its tissue distribution. Weekly IM (intramuscular) injections of iron-dextran (Imferon at 30 mg kg-1) improved the anemia but did not alter the red cell morphology. Certain diets also improved the health of b/b rats when compared to standard rat chows by the criteria of weight, survival to adulthood, hematology and reproduction. The critical nutritional factor turned out to be iron bioavailability, with ferrous iron added to the diet improving the health of Belgrade rats without affecting the underlying erythroid defect. Tissue iron measurements after dietary or parenteral supplementation confirmed the iron deficient status of untreated b/b rats and established that dietary ferrous iron partially relieved this deficiency, with injections leading to greater amounts of tissue iron, Serum iron and TIBC were also found to be elevated in untreated b/b rats, with dietary supplementation decreasing but not eliminating the elevation in TIBC. These studies indicate that iron supplements can improve the health of b/b rats without altering the underlying defect and also suggest that the mutation could alter iron uptake in the GI (gastrointestinal) tract.

KW - Belgrade rat

KW - Dietary iron

KW - Ferrous

KW - Parenteral iron

KW - Serum iron

UR - http://www.scopus.com/inward/record.url?scp=8244263621&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8244263621&partnerID=8YFLogxK

M3 - Article

VL - 10

SP - 65

EP - 76

JO - BioMetals

JF - BioMetals

SN - 0966-0844

IS - 2

ER -